In the last 12 months, insiders at Barinthus Biotherapeutics plc. ($BRNS) filed 21 transactions with the SEC: 0 open-market purchases totaling $0 and 0 sales totaling $0. Net insider sentiment: neutral.
Barinthus Biotherapeutics plc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Phillips Anne M. (Director) — 2 transactions totaling $0
- Griffiths Graham (Chief Business Officer) — 2 transactions totaling $0
- Hammacher Alex (Director) — 2 transactions totaling $0
- Pelletier Nadege (Chief Scientific Officer) — 1 transaction totaling $0
- Morgon Pierre A. (Director) — 2 transactions totaling $0
View all SEC Filings for Barinthus Biotherapeutics plc. (BRNS).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| June 10, 2025 | Hammacher Alex | Director | A | Share Option (Right to Buy) | 20174 | $0.00 | 20,174.0000 | 40,339,395 | 9999.99% | 0.05% |
| June 10, 2025 | Wright Robin | Director | A | Share Option (Right to Buy) | 20174 | $0.00 | 20,174.0000 | 40,339,395 | 9999.99% | 0.05% |
| June 10, 2025 | Morgon Pierre A. | Director | A | Share Option (Right to Buy) | 20174 | $0.00 | 20,174.0000 | 40,339,395 | 9999.99% | 0.05% |
| June 10, 2025 | Phillips Anne M. | Director | A | Share Option (Right to Buy) | 20174 | $0.00 | 20,174.0000 | 40,339,395 | 9999.99% | 0.05% |
| June 10, 2025 | Scheeren Joseph | Director | A | Share Option (Right to Buy) | 20174 | $0.00 | 20,174.0000 | 40,339,395 | 9999.99% | 0.05% |
| June 10, 2025 | DAWES KAREN A | Director | A | Share Option (Right to Buy) | 20174 | $0.00 | 20,174.0000 | 40,339,395 | 9999.99% | 0.05% |
| Feb. 3, 2025 | Brown Gemma | Chief Financial Officer | A | Share Option (Right to Buy) | 160000 | $0.00 | 160,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 3, 2025 | Enright William | Chief Executive Officer | A | Share Option (Right to Buy) | 600000 | $0.00 | 600,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 3, 2025 | Griffiths Graham | Chief Business Officer | A | Share Option (Right to Buy) | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 3, 2025 | Hooftman Leon | Chief Medical Officer | A | Share Option (Right to Buy) | 140000 | $0.00 | 140,000.0000 | 0 | 9999.99% | 0.00% |
| June 3, 2024 | Hooftman Leon | Chief Medical Officer | A | Share Option (Right to Buy) | 195166 | $0.00 | 195,166.0000 | 0 | 9999.99% | 0.00% |
| May 10, 2024 | DAWES KAREN A | Director | A | Share Option (Right to Buy) | 19516 | $0.00 | 19,516.0000 | 0 | 9999.99% | 0.00% |
| May 10, 2024 | Scheeren Joseph | Director | A | Share Option (Right to Buy) | 19516 | $0.00 | 19,516.0000 | 0 | 9999.99% | 0.00% |
| May 10, 2024 | Phillips Anne M. | Director | A | Share Option (Right to Buy) | 19516 | $0.00 | 19,516.0000 | 0 | 9999.99% | 0.00% |
| May 10, 2024 | Hammacher Alex | Director | A | Share Option (Right to Buy) | 19516 | $0.00 | 19,516.0000 | 0 | 9999.99% | 0.00% |
| May 10, 2024 | Morgon Pierre A. | Director | A | Share Option (Right to Buy) | 19516 | $0.00 | 19,516.0000 | 0 | 9999.99% | 0.00% |
| May 10, 2024 | Wright Robin | Director | A | Share Option (Right to Buy) | 19516 | $0.00 | 19,516.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2024 | Pelletier Nadege | Chief Scientific Officer | A | Share Option (Right to Buy) | 105000 | $0.00 | 105,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2024 | Griffiths Graham | Chief Business Officer | A | Share Option (Right to Buy) | 96500 | $0.00 | 96,500.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2024 | Enright William | Chief Executive Officer | A | Share Option (Right to Buy) | 443981 | $0.00 | 443,981.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2024 | Brown Gemma | Chief Financial Officer | A | Share Option (Right to Buy) | 193000 | $0.00 | 193,000.0000 | 0 | 9999.99% | 0.00% |